Skip to main content
OpenTrials
Completed

NCT Number: NCT01937676

LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting

The purpose of this study is evaluate if K3, a novel biomarker, sampled at arrival to the emergency department can be used to predict the development of organ failure measured as SOFA score. K3 consists of lactate dehydrogenase, albumin and magnesium combined.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Organ Failure Pathologic Processes Pathological Conditions, Signs and Symptoms Shock

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Karlstad Central Hospital

Karlstad, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • Admitted to emergency department, Karlstad Central Hospital, Sweden

Exclusion criteria

  • Not in need of venous blood sample

Treatment and study plan

Primary outcomes

  1. Development of multiple organ failure

    Time frame: 30 days or complete ICU stay

    Measured as SOFA score.

Secondary outcomes

  1. Cardiac function

    Time frame: 30 days or complete ICU stay

    Is it possible to predict cardiac function with the novel biomarker K3, which consists of lactate dehydrogenase, albumin, and magnesium combined?

  2. All cause mortality

    Time frame: 30 days after admission to emergency department

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
First posted
Sep 9, 2013
Registry last updated
Sep 7, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.